共 335 条
[1]
LeRoy EC(1988)Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202-205
[2]
Black C(2017)Systemic sclerosis sine scleroderma Adv Clin Exp Med 26 875-880
[3]
Fleischmajer R(2016)Hand impairment in systemic sclerosis: various manifestations and currently available treatment Curr Treatm Opt Rheumatol 2 252-269
[4]
Kucharz EJ(2000)Hand mobility in scleroderma (HAMIS) test: the reliability of a novel hand function test Arthritis Care Res 13 369-374
[5]
Kopeć-Mędrek M(1991)Arthritis hand function test: development of a standardized assessment tool Occup Ther J Res 11 245-256
[6]
Young A(1996)Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap J Rheumatol 23 1167-1172
[7]
Namas R(2004)Reliability and validity of the Duruoz hand index in persons with systemic sclerosis (scleroderma) Arthritis Rheum 51 805-809
[8]
Dodge C(1980)Measurement of patient outcome in arthritis Arthritis Rheum 23 137-145
[9]
Khanna D(2011)Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS
[10]
Sandqvist G(1997)The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time Arthritis Rheum 40 1984-1991